FGFR1 and non-small cell lung carcinoma: Fibroblast growth factor receptor 1 (FGFR1) amplification in NSCLC is particularly prevalent, especially in LSCC (76, 77), where it stimulates the expressions of Gli2 through ERK pathway activation.